...
机译:与头部和颈部鳞状细胞癌的开发相关的HLA特征影响患者的无进展生存期
Univ Hosp Leipzig Clin Otorhinolaryngol Head &
Neck Surg Liebigstr 10-14 D-04103 Leipzig Germany;
Univ Hosp Leipzig Clin Otorhinolaryngol Head &
Neck Surg Liebigstr 10-14 D-04103 Leipzig Germany;
Univ Hosp Leipzig Clin Otorhinolaryngol Head &
Neck Surg Liebigstr 10-14 D-04103 Leipzig Germany;
Univ Hosp Leipzig Clin Otorhinolaryngol Head &
Neck Surg Liebigstr 10-14 D-04103 Leipzig Germany;
Univ Hosp Leipzig Clin Otorhinolaryngol Head &
Neck Surg Liebigstr 10-14 D-04103 Leipzig Germany;
Univ Hosp Leipzig Clin Otorhinolaryngol Head &
Neck Surg Liebigstr 10-14 D-04103 Leipzig Germany;
Univ Hosp Leipzig Clin Otorhinolaryngol Head &
Neck Surg Liebigstr 10-14 D-04103 Leipzig Germany;
Univ Hosp Leipzig Clin Otorhinolaryngol Head &
Neck Surg Liebigstr 10-14 D-04103 Leipzig Germany;
Head and neck squamous cell carcinoma (HNSCC); Head and neck cancer epidemiology; Human leukocyte Antigen (HLA); HLA haplotype; Progression-free survival (PFS); Genetic susceptibility; Cancer epidemiology; T-cell response; Tumor-associated antigen (TAA); Neoantigen;
机译:与头部和颈部鳞状细胞癌的开发相关的HLA特征影响患者的无进展生存期
机译:用诱导化疗治疗的局部先进头和颈部鳞状细胞癌患者患者的无进展生存相关的预后因素,其次进行化学疗法
机译:新诊断的鳞状细胞癌和头颈癌患者中与严重治疗相关的淋巴细胞减少症与无进展生存之间的关联
机译:利用人工神经网络从肺癌患者的放射学特征中预测鳞状细胞癌的生存率
机译:表皮生长因子受体和核因子κB通路对头颈部鳞状细胞癌患者的预后潜力及相关治疗策略。
机译:人类白细胞抗原评分的发展以预测头颈部鳞状细胞癌患者的无进展生存期
机译:SMLRP1 / LRP1得分是头部和颈部鳞状细胞癌(HNSCC)的无进展(PFS)和整体存活(OS)的预测因子